Next 10 |
2024-04-13 20:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 16:49:42 ET Summary AngioDynamics has sold low-growth businesses, shifted to an outsourced manufacturing model, and refocused on cardiovascular and oncological care for potential growth. The recent approval of the AlphaVac F18 mechanical thrombectomy system for pulmonar...
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 PR Newswire ALAMEDA, Calif. , April 9, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial result...
2024-04-04 11:12:55 ET More on Health Care Select Sector SPDR: XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli...
2024-03-27 16:05:32 ET Summary Inari Medical, Inc.'s share price has dropped due to an investigation on doctor payment practices, creating a buying opportunity for risk-willing investors. Inari creates mechanical thrombectomy products for VTE and PE, with high potential operating ...
2024-03-27 15:04:20 ET More on J&J, ShockWave Medical, etc. Johnson & Johnson (JNJ) Barclays 26th Annual Global Healthcare Conference (Transcript) Johnson & Johnson (JNJ) Leerink Partners Global Biopharma Conference (Transcript) Johnson & Johnson (JNJ...
2024-02-23 12:46:54 ET More on Penumbra Penumbra, Inc. (PEN) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Penumbra Historical earnings data for Penumbra Financial information for Penumbra Read the full article on Seeking A...
2024-02-22 20:55:04 ET Penumbra, Inc. (PEN) Q4 2023 Earnings Conference Call February 22, 2024 4:30 PM ET Company Participants Jee Hamlyn-Harris – Investor Relations Adam Elsesser – Chairman and Chief Executive Officer Maggie Yuen – Chief Fin...
2024-02-22 16:38:06 ET More on Penumbra Seeking Alpha’s Quant Rating on Penumbra Historical earnings data for Penumbra Financial information for Penumbra Read the full article on Seeking Alpha For further details see: Penumbra GAAP EPS of $...
2024-02-22 16:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
2024-04-13 20:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 PR Newswire ALAMEDA, Calif. , April 9, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial result...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over Penumbra, Inc. (NYSE: PE...